Progression of motor deficits in glioma-bearing mice: impact of CNF1 therapy at symptomatic stages

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1A Robotic System for Quantitative Assessment and Poststroke Training of Forelimb Retraction in Mice2013 · 55 citations
2. 2Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: Analysis of single-agent and combined modality approaches2011 · 92 citations
3. 3Prolongation of Survival of Mice with Glioma Treated with Semiallogeneic Fibroblasts Secreting Interleukin-21999 · 48 citations
4. 4The bacterial protein toxin, cytotoxic necrotizing factor 1 (CNF1) provides long-term survival in a murine glioma model2014 · 25 citations
5. 5Cytotoxic Necrotizing Factors (CNFs)−A Growing Toxin Family2010 · 54 citations